Department of Pediatrics, 12358BC Children's Hospital Research Institute and University of British Columbia, Vancouver, BC, Canada.
Provincial Specialized Eating Disorders Program for Children & Adolescents, BC Children's Hospital, Vancouver, BC, Canada.
Clin Child Psychol Psychiatry. 2022 Apr;27(2):385-398. doi: 10.1177/13591045211048170. Epub 2021 Nov 13.
Certain presentations of Avoidant/Restrictive Food Intake Disorder (ARFID) and Somatic Symptom and Related Disorders (SSRDs) have conceptual overlap, namely, distress and impairment related to a physical symptom. This study compared characteristics of pediatric patients diagnosed with ARFID to those with gastrointestinal (GI)-related SSRD. A 5-year retrospective chart review at a tertiary care pediatric hospital comparing assessment data of patients with a diagnosis of ARFID ( = 62; 69% girls, = 14.08 years) or a GI-related SSRD ( = 37; 68% girls, = 14.25 years). Patients diagnosed with ARFID had a significantly lower percentage of median BMI than those with GI-related SSRD. Patients diagnosed with ARFID were most often assessed in the Eating Disorders Program, whereas patients diagnosed with an SSRD were most often assessed by Consultation-Liaison Psychiatry. Groups did not differ on demographics, psychiatric diagnoses, illness duration, or pre-assessment services/medications. GI symptoms were common across groups. Patients diagnosed with an SSRD had more co-occurring medical diagnoses. A subset (16%) of patients reported symptoms consistent with both diagnoses. Overlap is observed in the clinical presentation of pediatric patients diagnosed with ARFID or GI-related SSRD. Some group differences emerged, including anthropometric measurements and co-occurring medical conditions. Findings may inform diagnostic classification and treatment approach.
某些回避/限制型食物摄入障碍 (ARFID) 和躯体症状及相关障碍 (SSRDs) 的表现存在概念上的重叠，即与身体症状相关的痛苦和功能障碍。本研究比较了被诊断为 ARFID 的儿科患者与胃肠道 (GI) 相关 SSRD 患者的特征。在一家三级儿科医院进行了一项为期 5 年的回顾性图表审查，比较了被诊断为 ARFID ( = 62; 69%为女孩， = 14.08 岁) 或胃肠道相关 SSRD ( = 37; 68%为女孩， = 14.25 岁) 的患者的评估数据。与胃肠道相关 SSRD 患者相比，被诊断为 ARFID 的患者的 BMI 中位数百分比显著更低。被诊断为 ARFID 的患者主要在饮食失调计划中接受评估，而被诊断为 SSRD 的患者主要在联络精神病学中接受评估。两组在人口统计学、精神科诊断、疾病持续时间或预评估服务/药物方面无差异。两组患者均有常见的胃肠道症状。与 ARFID 患者相比，被诊断为 SSRD 的患者有更多的共病医疗诊断。约 16%的患者报告有符合两种诊断的症状。在被诊断为 ARFID 或胃肠道相关 SSRD 的儿科患者的临床表现中观察到重叠。出现了一些组间差异，包括人体测量指标和共病情况。研究结果可能为诊断分类和治疗方法提供信息。
